Short Term Results of Transscleral Diode Laser Cyclophotocoagulation for Childhood Glaucoma: A Case Series
Paediatric Ophthamology & Strabismus
Abstract
Introduction: The diagnosis and treatment of paediatric glaucoma has remained challenging despite developments in research and
technology.1,2 Due to young age; management is life-long and long-term outcomes may be uncertain. Management of paediatric glaucomas usually involves various surgical procedures.3,4 Cyclodestructive procedures entail ablation of the secretory epithelium of the ciliary body leading to reduced aqueous humour secretion and ultimately reduction of intraocular pressure. The aim of this study was to assess the short-term results of trans-scleral diode laser cyclophotocoagulation (TDLC) in Nigerian children with advanced primary glaucoma.
Methods: Hospital records of children with advanced primary glaucoma who had TDLC between November 2016 and February 2017 were reviewed.
References
Yu Chan JY, Choy BNK, Alex LK Ng, Shum JWH. eview on the Management of Primary Congenital Glaucoma. J Curr Glaucoma Pract 2015;9(3):92-99.
Autrata R, Lokaj M, Rehurek J. Trans-scleral diode laser cyclophotocoagulation in children with refractory glaucoma. Long-term outcomes. Scripta Medica (Brno) 2003; 76:67-78
Arif OK. A surgical approach to pediatric glaucoma. Open Ophthalmol J. 2015; 9: 104–112.
Jose M, Sami AS, Sami AO, Ibrahim AJ, Deepak PE. Current surgical options for the management of pediatric glaucoma. Journal of Ophthalmology; 2013:
Kirwan JF, Shah P, Khaw PT. Diode Laser Cyclophotocoagulation Role in the Management of Refractory Pediatric Glaucomas. Ophthalmology 2002; 109: 316–323
Babak E, Anjana PJ, JoAnn AG. Cyclodestructive Procedures in Treatment of Glaucoma :// eyewiki.aao.org/cyclodestructive _Procedures_ in_Treatment_ of Glaucoma. Accessed 24/07/ 17
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Transactions of the Ophthalmological Society of Nigeria
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.